文献速递复苏、休克与脓毒症儿科与产科急症

儿童脓毒症血清中可检测到的含血小板反应蛋白基序的解整合素和金属蛋白酶-1与不良结局相关

Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis.
PubMed 文献 · Crit Care Explor · 2021-11-08
一句话结论在儿童细菌感染中,入院48小时内可检测到含血小板反应蛋白基序的解整合素和金属蛋白酶-1(ADAMTS-1)与死亡相关,尤其在脑膜炎球菌脓毒症中。

本研究基于两项前瞻性队列研究,探讨儿童脓毒症中含血小板反应蛋白基序的解整合素和金属蛋白酶-1(ADAMTS-1)蛋白水平及其与结局的关联。队列1为单中心研究,纳入59例因脑膜炎球菌脓毒症入住PICU的儿童;队列2为多中心研究,纳入240例因不同病因侵袭性细菌感染住院的儿童。结果显示,在队列1中,非幸存者入住PICU时ADAMTS-1水平高于检测限的比例显著高于幸存者(73% vs 26%,p=0.02),24小时时亦显著(67% vs 8%,p=0.04);在队列2中,患者入院48小时内ADAMTS-1高于检测限的比例高于健康对照(46% vs 22%,p=0.001),非幸存者高于幸存者(76% vs 43%,p=0.003),且主要归因于脑膜炎奈瑟菌感染患者。结论认为,在儿童细菌感染中,入院48小时内检测到ADAMTS-1与死亡相关,尤其在脑膜炎球菌脓毒症中;未来研究应确认其预后价值并探讨病理生理机制。

要点

  • 在儿童脑膜炎球菌脓毒症中,入住PICU时ADAMTS-1高于检测限者死亡比例更高(非幸存者8/11 [73%] vs 幸存者6/23 [26%],p=0.02)。
  • 同一队列24小时时,非幸存者ADAMTS-1高于检测限比例仍高于幸存者(2/3 [67%] vs 3/37 [8%],p=0.04)。
  • 在儿童侵袭性细菌感染中,入院48小时内ADAMTS-1高于检测限的比例高于健康对照(110/240 [46%] vs 14/64 [22%],p=0.001)。
  • 非幸存者ADAMTS-1可检测到的比例高于幸存者(16/21 [76%] vs 94/219 [43%],p=0.003),主要归因于脑膜炎奈瑟菌感染患者。

适用人群与场景

  • 队列1:单中心研究,因脑膜炎球菌脓毒症入住PICU的儿童,样本在三个时间点获取。
  • 队列2:多中心研究,因不同病因侵袭性细菌感染住院的儿童,样本在入院后48小时内获取。

研究设计与关键结果

  • 研究设计:两项前瞻性队列研究;主要结局为死亡率,次要结局为28天无PICU天数及住院时长。
  • 队列1(n=59):非幸存者入住PICU时ADAMTS-1高于检测限比例高于幸存者(8/11 [73%] vs 6/23 [26%],p=0.02);24小时时非幸存者高于幸存者(2/3 [67%] vs 3/37 [8%],p=0.04)。
  • 队列2(n=240):入院48小时内ADAMTS-1高于检测限比例高于健康对照(110/240 [46%] vs 14/64 [22%],p=0.001);非幸存者高于幸存者(16/21 [76%] vs 94/219 [43%],p=0.003),主要归因于脑膜炎奈瑟菌感染患者。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究(两项)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在儿童细菌感染中,入院48小时内检测到ADAMTS-1与死亡相关,尤其在脑膜炎球菌脓毒症中,作者认为未来研究应确认其预后价值并探讨病理生理机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 is hypothesized to play a role in the pathogenesis of invasive infection, but studies in sepsis are lacking.

OBJECTIVES: To study A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 protein level in pediatric sepsis and to study the association with outcome.

DESIGN: Data from two prospective cohort studies.

SETTING AND PARTICIPANTS: Cohort 1 is from a single-center study involving children admitted to PICU with meningococcal sepsis (samples obtained at three time points). Cohort 2 includes patients from a multicenter study involving children admitted to the hospital with invasive bacterial infections of differing etiologies (samples obtained within 48 hr after hospital admission).

MAIN OUTCOMES AND MEASURES: Primary outcome measure was mortality. Secondary outcome measures were PICU-free days at day 28 and hospital length of stay.

RESULTS: In cohort 1 (n = 59), nonsurvivors more frequently had A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels above the detection limit than survivors at admission to PICU (8/11 [73%] and 6/23 [26%], respectively; p = 0.02) and at t = 24 hours (2/3 [67%] and 3/37 [8%], respectively; p = 0.04). In cohort 2 (n = 240), A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels in patients within 48 hours after hospital admission were more frequently above the detection limit than in healthy controls (110/240 [46%] and 14/64 [22%], respectively; p = 0.001). Nonsurvivors more often had detectable A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels than survivors (16/21 [76%] and 94/219 [43%], respectively; p = 0.003), which was mostly attributable to patients with Neisseria meningitidis.

CONCLUSIONS AND RELEVANCE: In children with bacterial infection, detection of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 within 48 hours after hospital admission is associated with death, particularly in meningococcal sepsis. Future studies should confirm the prognostic value of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 and should study pathophysiologic mechanisms.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Boeddha NP, Driessen GJ, Hagedoorn NN, et al. Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis. Crit Care Explor. 2021. PMID: 34765980. doi:10.1097/CCE.0000000000000569

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。